Financial Year |
March 31 2023 |
Monetary Funds |
72,644,742,347.73 |
Held-for-trading Financial Assets |
8,243,225,865.46 |
Notes Receivable |
10,246,054,734.14 |
Accounts Receivable |
29,350,977,871.84 |
Advances to Suppliers |
1,936,904,886.64 |
Other Receivables |
1,611,858,057.94 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
122,186,368.79 |
Dividend Receivable |
-- |
Inventories |
35,329,671,565.70 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
4,039,108,313.50 |
Other Current Assets |
3,317,031,237.78 |
Total Current Assets |
181,778,663,672.40 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
10,676,649,711.00 |
Long-term Equity Investment |
5,148,886,198.20 |
Investment Properties |
642,272,620.41 |
Fixed Assetes |
38,720,005,911.42 |
Under-construction Projects |
7,834,030,740.60 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
22,538,914,417.54 |
R&D expenses |
339,255,850.35 |
Goodwill |
23,943,823,290.75 |
Long-Term Deferred and Prepaid Expenses |
306,561,772.93 |
Deferred Income Tax Assets |
4,603,874,584.32 |
Other Non-Current Assets |
912,052,657.45 |
Sub-Total of Non-Current Assets |
125,702,386,737.67 |
Total Assets |
307,481,050,410.07 |
Short-Term Loans |
5,651,561,379.26 |
Trading Financial liabilities |
58,224,770.50 |
Notes Payable |
16,931,251,781.29 |
Accounts Payable |
60,505,114,043.57 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
6,187,734,032.79 |
Taxes Payable |
1,925,899,316.31 |
Interest Payable |
116,082,852.16 |
Dividend Payable |
301,596,611.57 |
Other payables |
8,908,490,407.36 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
9,840,242,492.50 |
Other Current Liabilities |
7,199,481,927.83 |
Sub-Total of Current Liabilities |
129,735,691,310.86 |
Long-term Loans |
23,094,606,789.92 |
Bonds Payable |
6,120,810,611.50 |
Long-Term Accounts Payable |
8,346,502,133.55 |
Special Payable |
-- |
Estimatied Liabilities |
849,751,131.27 |
Deferred Income Tax Liabilities |
4,184,889,132.28 |
Other Non-Current Liabilities |
12,390,728,592.21 |
Sub-Total of Non-Current Liabilities |
70,767,220,360.34 |
Total Liabilities |
200,502,911,671.20 |
Paid-In Capital(Or Share Stock) |
8,726,556,821.00 |
Capital Surplus |
11,350,199,586.08 |
Surplus Reserve |
2,765,811,169.85 |
LESS:Treasury Stock |
1,036,022,358.39 |
Undistributed Profits |
52,186,360,505.72 |
Minority Stockholder's Interest |
31,400,224,805.86 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
75,577,913,933.01 |
Owner's Equity(Stockholder's Equity) |
106,978,138,738.87 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
307,481,050,410.07 |